Gene therapy for human osteoarthritis: principles and clinical translation

Bibliography

• Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.
   Google Scholar
• Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377(9783):2115–2126.
   PubMed Web of Science ®Google Scholar
• Goldring MB. Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther Adv Musculoskelet Dis. 2012;4(4):269–285.
   PubMedGoogle Scholar
• Goldring MB, Marcu KB. Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritis. Trends Mol Med. 2011;18(2):109–118.
   PubMed Web of Science ®Google Scholar
• Loeser RF, Goldring SR, Scanzello CR, et al. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64(6):1697–1707.
   PubMed Web of Science ®Google Scholar

•• Interesting review on osteoarthritis.

• Evans CH, Kraus VB, Setton LA. Progress in intra-articular therapy. Nat Rev Rheumatol. 2014;10(1):11–22.
   PubMed Web of Science ®Google Scholar
• McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014;22(3):363–388.doi:10.1016/j.joca.2014.01.003.
   PubMed Web of Science ®Google Scholar
• Evans CH, Huard J. Gene therapy approaches to regenerating the musculoskeletal system. Nat Rev Rheumatol. 2015;11(4):234–242.
   PubMed Web of Science ®Google Scholar
• Hunziker EB, Kapfinger E, Geiss J. The structural architecture of adult mammalian articular cartilage evolves by a synchronized process of tissue resorption and neoformation during postnatal development. Osteoarthr Cartil. 2007;15(4):403–413.
   PubMed Web of Science ®Google Scholar
• Mankin HJ. The structure, chemistry and metabolism of articular cartilage. Bull Rheum Dis. 1967;17(7):447–452.
   PubMedGoogle Scholar
• Hunziker EB, Quinn TM, Hauselmann HJ. Quantitative structural organization of normal adult human articular cartilage. Osteoarthr Cartil. 2002;10(7):564–572.
   PubMed Web of Science ®Google Scholar
• Madry H, Van Dijk CN, Mueller-Gerbl M. The basic science of the subchondral bone. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):419–433.
   PubMed Web of Science ®Google Scholar
• Roughley PJ, Mort JS. The role of aggrecan in normal and osteoarthritic cartilage. J Exp Orthop. 2014;1:8.
   PubMedGoogle Scholar
• Kraus VB, Blanco FJ, Englund M, et al. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthr Cartil. 2015;23(8):1233–1241.
   PubMed Web of Science ®Google Scholar
• Pritzker KP, Gay S, Jimenez SA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartil. 2006;14(1):13–29.
   PubMed Web of Science ®Google Scholar
• Kraus VB, Feng S, Wang S, et al. Subchondral bone trabecular integrity predicts and changes concurrently with radiographic and magnetic resonance imaging-determined knee osteoarthritis progression. Arthritis Rheum. 2013;65(7):1812–1821.
   PubMed Web of Science ®Google Scholar
• Madry H, Luyten FP, Facchini A. Biological aspects of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2012;30(3):407–422.
   Web of Science ®Google Scholar
• Valdes AM, Spector TD. Genetic epidemiology of hip and knee osteoarthritis. Nat Rev Rheumatol. 2010;7(1):23–32.
   PubMed Web of Science ®Google Scholar
• Sandell LJ. Etiology of osteoarthritis: genetics and synovial joint development. Nat Rev Rheumatol. 2012;8(2):77–89.
   PubMed Web of Science ®Google Scholar
• Van Der Kraan PM. Osteoarthritis year 2012 in review: biology. Osteoarthr Cartil. 2012;20(12):1447–1450.
   PubMed Web of Science ®Google Scholar
• Heijink A, Gomoll AH, Madry H, et al. Biomechanical considerations in the pathogenesis of osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2012;20(3):423–435.
   PubMed Web of Science ®Google Scholar
• Felson DT. Osteoarthritis as a disease of mechanics. Osteoarthr Cartil. 2012;21(1):10–15.
   PubMed Web of Science ®Google Scholar
• Englund M, Lohmander LS. Risk factors for symptomatic knee osteoarthritis fifteen to twenty-two years after meniscectomy. Arthritis Rheum. 2004;50(9):2811–2819.
   PubMed Web of Science ®Google Scholar
• Lievense AM, Bierma-Zeinstra SM, Verhagen AP, et al. Influence of hip dysplasia on the development of osteoarthritis of the hip. Ann Rheum Dis. 2004;63(6):621–626.
   PubMed Web of Science ®Google Scholar
• Brandt KD, Lohmander LS, Doherty M. Pathogenesis of osteoarthritis - Introduction: the concept of osteoarthritis as failure of the diarthrodial joint. In: Brandt KD, Lohmander LS, Doherty M, eds. Osteoarthritis. New York (NY): Oxford University Press; 1998. p. 70–74.
   Google Scholar
• Krasnokutsky S, Belitskaya-Levy I, Bencardino J, et al. Quantitative MRI evidence of synovial proliferation is associated with radiographic severity of knee osteoarthritis. Arthritis Rheum. 2011;63(10):2983–2991. doi:10.1002/art.30471
   Web of Science ®Google Scholar
• Orlowsky EW, Kraus VB. The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive. J Rheumatol. 2015;42(3):363–371.
   PubMed Web of Science ®Google Scholar
• Madry H, Cucchiarini M. Advances and challenges in gene-based approaches for osteoarthritis. J Gene Med. 2013;15(10):343–355.
   PubMed Web of Science ®Google Scholar
• Madry H, Trippel SB. Efficient lipid-mediated gene transfer to articular chondrocytes. Gene Ther. 2000;7(4):286–291.
   PubMed Web of Science ®Google Scholar
• Elsler S, Schetting S, Schmitt G, et al. Effective, safe nonviral gene transfer to preserve the chondrogenic differentiation potential of human mesenchymal stem cells. J Gene Med. 2012;14(7):501–511.
   PubMed Web of Science ®Google Scholar
• Madry H, Cucchiarini M. Clinical potential and challenges of using genetically modified cells for articular cartilage repair. Croat Med J. 2011;52(3):245–261.
   PubMed Web of Science ®Google Scholar
• Baragi VM, Renkiewicz RR, Jordan H, et al. Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. J Clin Invest. 1995;96(5):2454–2460.
   PubMed Web of Science ®Google Scholar
• Doherty PJ, Zhang H, Tremblay L, et al. Resurfacing of articular cartilage explants with genetically-modified human chondrocytes in vitro. Osteoarthr Cartil. 1998;6(3):153–159.
   PubMed Web of Science ®Google Scholar
• Nixon AJ, Brower-Toland BD, Bent SJ, et al. Insulinlike growth factor-I gene therapy applications for cartilage repair. Clin Orthop. 2000;43(379 Suppl):S201–13.
   Google Scholar
• Ikeda T, Kubo T, Arai Y, et al. Adenovirus mediated gene delivery to the joints of guinea pigs. J Rheumatol. 1998;25(9):1666–1673.
   PubMed Web of Science ®Google Scholar
• Allay JA, Dennis JE, Haynesworth SE, et al. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum Gene Ther. 1997;8(12):1417–1427.
   PubMed Web of Science ®Google Scholar
• Madry H, Orth P, Cucchiarini M. Gene therapy for cartilage repair. Cartilage. 2011;2(3):201–225.
   PubMed Web of Science ®Google Scholar
• Gouze E, Pawliuk R, Pilapil C, et al. In vivo gene delivery to synovium by lentiviral vectors. Mol Ther. 2002;5(4):397–404.
   PubMed Web of Science ®Google Scholar
• Meyerrose TE, Roberts M, Ohlemiller KK, et al. Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease. Stem Cells. 2008;26(7):1713–1722.
   PubMed Web of Science ®Google Scholar
• Arai Y, Kubo T, Fushiki S, et al. Gene delivery to human chondrocytes by an adeno associated virus vector. J Rheumatol. 2000;27(4):979–982.
   PubMed Web of Science ®Google Scholar
• Madry H, Cucchiarini M, Terwilliger EF, et al. Efficient and persistent gene transfer into articular cartilage using recombinant adeno-associated virus vectors in vitro and in vivo. Human Gene Ther. 2003;14(4):393–402.
   PubMed Web of Science ®Google Scholar
• Stender S, Murphy M, O’Brien T, et al. Adeno-associated viral vector transduction of human mesenchymal stem cells. Eur Cell Mater. 2007;13:93–99. discussion 9.
   PubMed Web of Science ®Google Scholar
• Cucchiarini M, Ekici M, Schetting S, et al. Metabolic activities and chondrogenic differentiation of human mesenchymal stem cells following recombinant adeno-associated virus-mediated gene transfer and overexpression of fibroblast growth factor 2. Tissue Eng Part A. 2011;17(15–16):1921–1933.
   PubMed Web of Science ®Google Scholar
• Venkatesan JK, Ekici M, Madry H, et al. SOX9 gene transfer via safe, stable, replication-defective recombinant adeno-associated virus vectors as a novel, powerful tool to enhance the chondrogenic potential of human mesenchymal stem cells. Stem Cell Res Ther. 2012;3(3):22.
   PubMed Web of Science ®Google Scholar
• Goater J, Muller R, Kollias G, et al. Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis. J Rheumatol. 2000;27(4):983–989.
   PubMed Web of Science ®Google Scholar
• Duan C. Nutritional and developmental regulation of insulin-like growth factors in fish. J Nutr. 1998;128(2 Suppl):306S–14S.
   PubMed Web of Science ®Google Scholar
• Rey-Rico A, Frisch J, Venkatesan JK, et al. Determination of effective rAAV-mediated gene transfer conditions to support chondrogenic differentiation processes in human primary bone marrow aspirates. Gene Ther. 2014;22(1):50–57. doi:10.1038/gt.2014.90
   PubMed Web of Science ®Google Scholar
• Frisch J, Rey-Rico A, Venkatesan JK, et al. Chondrogenic differentiation processes in human bone marrow aspirates upon rAAV-mediated gene transfer and overexpression of the insulin-like growth factor I. Tissue Eng Part A. 2015;21(17–18):2460–2471.
   PubMed Web of Science ®Google Scholar
• Santangelo KS, Bertone AL. Effective reduction of the interleukin-1beta transcript in osteoarthritis-prone guinea pig chondrocytes via short hairpin RNA mediated RNA interference influences gene expression of mediators implicated in disease pathogenesis. Osteoarthr Cartil. 2011;19(12):1449–1457.
   PubMed Web of Science ®Google Scholar
• Watson RS, Broome TA, Levings PP, et al. scAAV-mediated gene transfer of interleukin-1-receptor antagonist to synovium and articular cartilage in large mammalian joints. Gene Ther. 2013;20(6):670–677. doi:10.1038/gt.2012.81
   PubMed Web of Science ®Google Scholar
• Goodrich LR, Phillips JN, McIlwraith CW, et al. Optimization of scAAVIL-1ra in vitro and in vivo to deliver high levels of therapeutic protein for treatment of osteoarthritis. Mol Ther Nucleic Acids. 2013;2:e70.
   PubMedGoogle Scholar
• Calcedo R, Wilson JM. Humoral immune response to AAV. Front Immunol. 2013;4:341.
   PubMed Web of Science ®Google Scholar
• Rey-Rico A, Venkatesan JK, Frisch J, et al. Effective and durable genetic modification of human mesenchymal stem cells via controlled release of rAAV vectors from self-assembling peptide hydrogels with a maintained differentiation potency. Acta Biomater. 2015;18:118–127.
   PubMed Web of Science ®Google Scholar
• Rey-Rico A, Venkatesan JK, Frisch J, et al. PEO-PPO-PEO micelles as effective rAAV-mediated gene delivery systems to target human mesenchymal stem cells without altering their differentiation potency. Acta Biomater. 2015;27:42–52.
   PubMed Web of Science ®Google Scholar
• Cucchiarini M, Madry H, Ma C, et al. Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2. Mol Ther. 2005;12(2):229–238.
   PubMed Web of Science ®Google Scholar
• Cucchiarini M, Terwilliger EF, Kohn D, et al. Remodelling of human osteoarthritic cartilage by FGF-2, alone or combined with Sox9 via rAAV gene transfer. J Cell Mol Med. 2009;13(8B):2476–2488.
   PubMed Web of Science ®Google Scholar
• Kaul G, Cucchiarini M, Arntzen D, et al. Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo. J Gene Med. 2006;8(1):100–111.
   PubMed Web of Science ®Google Scholar
• Cucchiarini M, Sohier J, Mitosch K, et al. Effect of transforming growth factor-beta 1 (TGF-ß1) released from a scaffold on chondrogenesis in an osteochondral defect model in the rabbit. Centr Eur J Biol. 2004;4(1):1–18.
   Google Scholar
• Schmal H, Mehlhorn AT, Zwingmann J, et al. Stimulation of chondrocytes in vitro by gene transfer with plasmids coding for epidermal growth factor (hEGF) and basic fibroblast growth factor (bFGF). Cytotherapy. 2005;7(3):292–300.
   PubMed Web of Science ®Google Scholar
• Goodrich LR, Hidaka C, Robbins PD, et al. Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br. 2007;89(5):672–685.
   PubMedGoogle Scholar
• Weimer A, Madry H, Venkatesan JK, et al. Benefits of rAAV-mediated IGF-I overexpression for the long-term reconstruction of human osteoarthritic cartilage bymodulation of the IGF-I axis. Mol Med. 2012;18(1):346–358.
   PubMed Web of Science ®Google Scholar
• Piera-Velazquez S, Jimenez SA, Stokes D. Increased life span of human osteoarthritic chondrocytes by exogenous expression of telomerase. Arthritis Rheum. 2002;46(3):683–693.
   PubMed Web of Science ®Google Scholar
• Shi S, Mercer S, Eckert GJ, et al. Growth factor transgenes interactively regulate articular chondrocytes. J Cell Biochem. 2012;114(4):908–919.
   Web of Science ®Google Scholar
• Surendran S, Kim SH, Jee BK, et al. Anti-apoptotic Bcl-2 gene transfection of human articular chondrocytes protects against nitric oxide-induced apoptosis. J Bone Joint Surg Br. 2006;88(12):1660–1665.
   PubMedGoogle Scholar
• Grossin L, Cournil-Henrionnet C, Pinzano A, et al. Gene transfer with HSP70 in rat chondrocytes confers cytoprotection in vitro and during experimental osteoarthritis. Faseb J. 2006;20(1):65–75.
   PubMed Web of Science ®Google Scholar
• Dai J, Rabie AB. Recombinant adeno-associated virus vector hybrids efficiently target different skeletal cells. Front Biosci. 2007;12:4280–4287.
   PubMed Web of Science ®Google Scholar
• Lianxu C, Hongti J, Changlong Y. NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes. Osteoarthr Cartil. 2006;14(4):367–376.
   PubMed Web of Science ®Google Scholar
• Amos N, Lauder S, Evans A, et al. Adenoviral gene transfer into osteoarthritis synovial cells using the endogenous inhibitor IkappaBalpha reveals that most, but not all, inflammatory and destructive mediators are NFkappaB dependent. Rheumatology (Oxford). 2006;45(10):1201–1209.
   PubMed Web of Science ®Google Scholar
• Chan TF, Couchourel D, Abed E, et al. Elevated Dickkopf-2 levels contribute to the abnormal phenotype of human osteoarthritic osteoblasts. J Bone Miner Res. 2011;26(7):1399–1410.
   PubMed Web of Science ®Google Scholar
• Oh H, Chun CH, Chun JS. Dkk-1 expression in chondrocytes inhibits experimental osteoarthritic cartilage destruction in mice. Arthritis Rheum. 2012;64(8):2568–2578.
   PubMed Web of Science ®Google Scholar
• Rhee J, Ryu JH, Kim JH, et al. alpha-Catenin inhibits beta-catenin-T-cell factor/lymphoid enhancing factor transcriptional activity and collagen type II expression in articular chondrocytes through formation of Gli3R.alpha-catenin.beta-catenin ternary complex. J Biol Chem. 2012;287(15):11751–11760.
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthr Cartil. 1998;6(5):374–376.
   PubMed Web of Science ®Google Scholar
• Brower-Toland BD, Saxer RA, Goodrich LR, et al. Direct adenovirus-mediated insulin-like growth factor I gene transfer enhances transplant chondrocyte function. Hum Gene Ther. 2001;12(2):117–129.
   PubMed Web of Science ®Google Scholar
• Chen B, Qin J, Wang H, et al. Effects of adenovirus-mediated bFGF, IL-1Ra and IGF-1 gene transfer on human osteoarthritic chondrocytes and osteoarthritis in rabbits. Exp Mol Med. 2010;42(10):684–695.
   PubMed Web of Science ®Google Scholar
• Cucchiarini M, Schetting S, Terwilliger EF, et al. rAAV-mediated overexpression of FGF-2 promotes cell proliferation, survival, and alpha-SMA expression in human meniscal lesions. Gene Ther. 2009;16(11):1363–1372.
   PubMed Web of Science ®Google Scholar
• Haupt JL, Frisbie DD, McIlwraith CW, et al. Dual transduction of insulin-like growth factor-I and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model. J Orthop Res. 2005;23(1):118–126.
   PubMed Web of Science ®Google Scholar
• Lee DK, Choi KB, Oh IS, et al. Continuous transforming growth factor beta1 secretion by cell-mediated gene therapy maintains chondrocyte redifferentiation. Tissue Eng. 2005;11(1–2):310–318.
   PubMedGoogle Scholar
• Madry H, Emkey G, Zurakowski D, et al. Overexpression of human fibroblast growth factor 2 stimulates cell proliferation in an ex vivo model of articular chondrocyte transplantation. J Gene Med. 2004;6(2):238–245.
   PubMed Web of Science ®Google Scholar
• Madry H, Reszka R, Bohlender J, et al. Efficacy of cationic-liposome mediated gene transfer to mesangial cells in vitro and in vivo. J Mol Med. 2001;79(4):184–189.
   PubMed Web of Science ®Google Scholar
• Nixon AJ, Haupt JL, Frisbie DD, et al. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy. Gene Ther. 2005;12(2):177–186.
   PubMed Web of Science ®Google Scholar
• Saxer RA, Bent SJ, Brower-Toland BD, et al. Gene mediated insulin-like growth factor-I delivery to the synovium. J Orthop Res. 2001;19(5):759–767.
   PubMed Web of Science ®Google Scholar
• Shuler FD, Georgescu HI, Niyibizi C, et al. Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes. J Orthop Res. 2000;18(4):585–592.
   PubMed Web of Science ®Google Scholar
• Smith P, Shuler FD, Georgescu HI, et al. Genetic enhancement of matrix synthesis by articular chondrocytes. J Rheumatol. 2000;43(5):1156–1164.
   Google Scholar
• Tsuchiya H, Kitoh H, Sugiura F, et al. Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun. 2003;301(2):338–343.
   PubMed Web of Science ®Google Scholar
• Ikeda T, Kamekura S, Mabuchi A, et al. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum. 2004;50(11):3561–3573.
   PubMed Web of Science ®Google Scholar
• Li Y, Tew SR, Russell AM, et al. Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9. Tissue Eng. 2004;10(3–4):575–584.
   PubMedGoogle Scholar
• Tew SR, Li Y, Pothacharoen P, et al. Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. Osteoarthr Cartil. 2005;13(1):80–89.
   PubMed Web of Science ®Google Scholar
• Ulrich-Vinther M, Stengaard C, Schwarz EM, et al. Adeno-associated vector mediated gene transfer of transforming growth factor-beta1 to normal and osteoarthritic human chondrocytes stimulates cartilage anabolism. Eur Cell Mater. 2005;10:40–59.
   PubMedGoogle Scholar
• Cucchiarini M, Thurn T, Weimer A, et al. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9. Arthritis Rheum. 2007;56(1):158–167.
   PubMed Web of Science ®Google Scholar
• Cao X, Deng W, Wei Y, et al. Incorporating pTGF-beta1/calcium phosphate nanoparticles with fibronectin into 3-dimensional collagen/chitosan scaffolds: efficient, sustained gene delivery to stem cells for chondrogenic differentiation. Eur Cell Mater. 2012;23:81–93.
   PubMed Web of Science ®Google Scholar
• Gavenis K, Schneider U, Wallich R, et al. Effects of low concentrated BMP-7 administered by co-cultivation or plasmid transfection on human osteoarthritic chondrocytes. Int J Artif Organs. 2010;33(6):339–347.
   PubMed Web of Science ®Google Scholar
• Kubo S, Cooper GM, Matsumoto T, et al. Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells. Arthritis Rheum. 2009;60(1):155–165.
   PubMed Web of Science ®Google Scholar
• Mi Z, Ghivizzani SC, Lechman ER, et al. Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints. Arthritis Rheum. 2000;43(11):2563–2570.
   PubMed Web of Science ®Google Scholar
• Neumann AJ, Alini M, Archer CW, et al. Chondrogenesis of human bone marrow-derived mesenchymal stem cells is modulated by complex mechanical stimulation and adenoviral-mediated overexpression of bone morphogenetic protein 2. Tissue Eng Part A. 2013;19(11–12):1285–1294. doi:10.1089/ten.TEA.2012.0411
   PubMed Web of Science ®Google Scholar
• Ng VY, Jump SS, Santangelo KS, et al. Genetic engineering of juvenile human chondrocytes improves scaffold-free mosaic neocartilage grafts. Clin Orthop Relat Res. 2012;471(1):26–38.
   PubMed Web of Science ®Google Scholar
• Palmer GD, Steinert A, Pascher A, et al. Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro. Mol Ther. 2005;12(2):219–228.
   PubMed Web of Science ®Google Scholar
• Shi S, Mercer S, Eckert GJ, et al. Regulation of articular chondrocyte aggrecan and collagen gene expression by multiple growth factor gene transfer. J Orthop Res. 2011;30(7):1026–1031.
   PubMed Web of Science ®Google Scholar
• Shi S, Mercer S, Eckert GJ, et al. Growth factor regulation of growth factor production by multiple gene transfer to chondrocytes. Growth Factors. 2013;31(1):32–38.
   PubMed Web of Science ®Google Scholar
• Steinert AF, Palmer GD, Pilapil C, et al. Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer. Tissue Eng Part A. 2009;15(5):1127–1139.
   PubMed Web of Science ®Google Scholar
• Steinert AF, Proffen B, Kunz M, et al. Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer. Arthritis Res Ther. 2009;11(5):R148.
   PubMed Web of Science ®Google Scholar
• Steinert AF, Weissenberger M, Kunz M, et al. Indian hedgehog gene transfer is a chondrogenic inducer of human mesenchymal stem cells. Arthritis Res Ther. 2012;14(4):R168.
   PubMed Web of Science ®Google Scholar
• Wang D, Taboas JM, Tuan RS. PTHrP overexpression partially inhibits a mechanical strain-induced arthritic phenotype in chondrocytes. Osteoarthr Cartil. 2010;19(2):213–221.
   PubMed Web of Science ®Google Scholar
• Lee JM, Im GI. SOX trio-co-transduced adipose stem cells in fibrin gel to enhance cartilage repair and delay the progression of osteoarthritis in the rat. Biomaterials. 2012;33(7):2016–2024.
   PubMed Web of Science ®Google Scholar
• Zhang F, Su K, Fang Y, et al. A mixed co-culture of mesenchymal stem cells and transgenic chondrocytes in alginate hydrogel for cartilage tissue engineering. J Tissue Eng Regen Med. 2015;9(1):77–84. doi:10.1002/term.1641
   Web of Science ®Google Scholar
• Zhang F, Yao Y, Su K, et al. Co-transduction of lentiviral and adenoviral vectors for co-delivery of growth factor and shRNA genes in mesenchymal stem cells-based chondrogenic system. J Tissue Eng Regen Med. 2015;9(9):1036–1045. doi:10.1002/term.1656
   Web of Science ®Google Scholar
• Zhang F, Yao Y, Zhou R, et al. Optimal construction and delivery of dual-functioning lentiviral vectors for type I collagen-suppressed chondrogenesis in synovium-derived mesenchymal stem cells. Pharm Res. 2010;28(6):1338–1348.
   PubMed Web of Science ®Google Scholar
• Kafienah W, Al-Fayez F, Hollander AP, et al. Inhibition of cartilage degradation: a combined tissue engineering and gene therapy approach. Arthritis Rheum. 2003;48(3):709–718.
   PubMed Web of Science ®Google Scholar
• Coughlan TC, Crawford A, Goldring MB, et al. Lentiviral shRNA knock-down of ADAMTS-5 and -9 restores matrix deposition in 3D chondrocyte culture. J Tissue Eng Regen Med. 2010;4(8):611–618.
   PubMed Web of Science ®Google Scholar
• Wang ZH, Yang ZQ, He XJ, et al. Lentivirus-mediated knockdown of aggrecanase-1 and -2 promotes chondrocyte-engineered cartilage formation in vitro. Biotechnol Bioeng. 2010;107(4):730–736.
   PubMed Web of Science ®Google Scholar
• Zhang HG, Xie J, Yang P, et al. Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor alpha and reduces arthritis. Hum Gene Ther. 2000;11(17):2431–2442.
   PubMed Web of Science ®Google Scholar
• Roessler BJ, Hartman JW, Vallance DK, et al. Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector. Hum Gene Ther. 1995;6(3):307–316.
   PubMed Web of Science ®Google Scholar

•• Milestone study on cartilage gene therapy in vivo.

• Gouze JN, Gouze E, Palmer GD, et al. A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer. Arthritis Res Ther. 2003;5(5):R301–9.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yu C, Xushi ZC, et al. Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo. Biochem Biophys Res Commun. 2006;341(1):202–208.
   PubMed Web of Science ®Google Scholar
• Attur MG, Dave MN, Leung MY, et al. Functional genomic analysis of type II IL-1beta decoy receptor: potential for gene therapy in human arthritis and inflammation. J Immunol. 2002;168(4):2001–2010.
   PubMed Web of Science ®Google Scholar
• Bandara G, Mueller GM, Galea-Lauri J, et al. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci U S A. 1993;90(22):10764–10768.
   PubMed Web of Science ®Google Scholar

•• Pioneering study on cartilage gene therapy in vivo.

• Frisbie DD, Ghivizzani SC, Robbins PD, et al. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther. 2002;9(1):12–20.
   PubMed Web of Science ®Google Scholar
• Nixon AJ, Goodrich LR, Scimeca MS, et al. Gene therapy in musculoskeletal repair. Ann N Y Acad Sci. 2007;1117:310–327.
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Caron JP, Evans C, et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum. 1997;40(6):1012–1019.
   PubMed Web of Science ®Google Scholar

•• Milestone study on cartilage gene therapy in vivo.

• Wang HJ, Yu CL, Kishi H, et al. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer. Chin Med J (Engl). 2006;119(16):1365–1373.
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim S, Evans CH, et al. Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4. J Immunol. 2001;166(5):3499–3505.
   PubMed Web of Science ®Google Scholar
• Lee JM, Im GI. SOX trio-co-transduced adipose stem cells in fibrin gel to enhance cartilage repair and delay the progression of osteoarthritis in the rat. Biomaterials. 2011;33(7):2016–2024.
   PubMed Web of Science ®Google Scholar
• Orth P, Kaul G, Cucchiarini M, et al. Transplanted articular chondrocytes co-overexpressing IGF-I and FGF-2 stimulate cartilage repair in vivo. Knee Surg Sports Traumatol Arthrosc. 2011;19(12):2119–2130.
   PubMed Web of Science ®Google Scholar
• Jeon SY, Park JS, Yang HN, et al. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs. Biomaterials. 2012;33(17):4413–4423.
   PubMed Web of Science ®Google Scholar
• Cook JL, Kuroki K, Visco D, et al. The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the dog. Osteoarthr Cartil. 2010;18(Suppl 3):S66–79.
   PubMed Web of Science ®Google Scholar
• Gerwin N, Bendele AM, Glasson S, et al. The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the rat. Osteoarthr Cartil. 2010;18(Suppl 3):S24–34.
   PubMed Web of Science ®Google Scholar
• Glasson SS, Chambers MG, Van Den Berg WB, et al. The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthr Cartil. 2010;18(Suppl 3):S17–23.
   PubMed Web of Science ®Google Scholar
• Kraus VB, Huebner JL, DeGroot J, et al. The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the guinea pig. Osteoarthr Cartil. 2010;18(Suppl 3):S35–52.
   PubMed Web of Science ®Google Scholar
• Laverty S, Girard CA, Williams JM, et al. The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the rabbit. Osteoarthr Cartil. 2010;18(Suppl 3):S53–65.
   PubMed Web of Science ®Google Scholar
• Little CB, Zaki S. What constitutes an “animal model of osteoarthritis” – the need for consensus?. Osteoarthr Cartil. 2012;20(4):261–267.
   PubMed Web of Science ®Google Scholar

• Review on animal models to evaluate osteoarthritis.

• Poole R, Blake S, Buschmann M, et al. Recommendations for the use of preclinical models in the study and treatment of osteoarthritis. Osteoarthr Cartil. 2010;18(Suppl 3):S10–16.
   PubMed Web of Science ®Google Scholar

• Review on animal models to evaluate osteoarthritis.

• Pap T, Muller-Ladner U, Gay R, et al. Gene therapy in rheumatoid arthritis: how to target joint destruction?. Arthritis Res. 1999;1(1):5–9.
   PubMedGoogle Scholar
• Goodrich LR, Brower-Toland BD, Warnick L, et al. Direct adenovirus-mediated IGF-I gene transduction of synovium induces persisting synovial fluid IGF-I ligand elevations. Gene Ther. 2006;13(17):1253–1262.
   PubMed Web of Science ®Google Scholar
• Fernandes J, Tardif G, Martel-Pelletier J, et al. In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. Am J Pathol. 1999;154(4):1159–1169.
   PubMed Web of Science ®Google Scholar

•• Milestone study on cartilage gene therapy in vivo.

• Frisbie DD, McIlwraith CW. Evaluation of gene therapy as a treatment for equine traumatic arthritis and osteoarthritis. Clin Orthop. 2000;379 Suppl:S273–87.
   Google Scholar
• Santangelo KS, Nuovo GJ, Bertone AL. In vivo reduction or blockade of interleukin-1beta in primary osteoarthritis influences expression of mediators implicated in pathogenesis. Osteoarthr Cartil. 2012;20(12):1610–1618.
   PubMed Web of Science ®Google Scholar
• Pi Y, Zhang X, Shao Z, et al. Intra-articular delivery of anti-Hif-2alpha siRNA by chondrocyte-homing nanoparticles to prevent cartilage degeneration in arthritic mice. Gene Ther. 2015;22(6):439–448. doi:10.1038/gt.2015.16
   PubMed Web of Science ®Google Scholar
• Chen LX, Lin L, Wang HJ, et al. Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA. Osteoarthr Cartil. 2008;16(2):174–184.
   PubMed Web of Science ®Google Scholar
• Shen PC, Shiau AL, Jou IM, et al. Inhibition of cartilage damage by pro-opiomelanocortin prohormone overexpression in a rat model of osteoarthritis. Exp Biol Med (Maywood). 2011;236(3):334–340.
   PubMed Web of Science ®Google Scholar
• Yamashita M, Yamauchi K, Suzuki M, et al. Transfection of rat cells with proopiomeranocortin gene, precursor of endogenous endorphin, using radial shock waves suppresses inflammatory pain. Spine. 2009;34(21):2270–2277. Phila Pa 1976.
   PubMed Web of Science ®Google Scholar
• Blaney Davidson EN, Vitters EL, Van Den Berg WB, et al. TGF beta-induced cartilage repair is maintained but fibrosis is blocked in the presence of Smad7. Arthritis Res Ther. 2006;8(3):R65.
   PubMed Web of Science ®Google Scholar
• Scharstuhl A, Vitters EL, Van Der Kraan PM, et al. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum. 2003;48(12):3442–3451.
   PubMed Web of Science ®Google Scholar
• Hsieh JL, Shen PC, Shiau AL, et al. Adenovirus-mediated kallistatin gene transfer ameliorates disease progression in a rat model of osteoarthritis induced by anterior cruciate ligament transection. Hum Gene Ther. 2009;20(2):147–158.
   PubMed Web of Science ®Google Scholar
• Hsieh JL, Shen PC, Shiau AL, et al. Intraarticular gene transfer of thrombospondin-1 suppresses the disease progression of experimental osteoarthritis. J Orthop Res. 2010;28(10):1300–1306.
   PubMed Web of Science ®Google Scholar
• Zhang X, Mao Z, Yu C. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10. J Orthop Res. 2004;22(4):742–750.
   PubMed Web of Science ®Google Scholar
• Benya PD, Padilla SR, Nimni ME. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell. 1978;15(4):1313–1321.
   PubMed Web of Science ®Google Scholar

• Early demonstration of the key phenotype switch in chondrocytes.

• Von Der Mark K, Gauss V, Von Der Mark H, et al. Relationship between cell shape and type of collagen synthesis as chondrocytes lose their cartilage phenotype in culture. Nature. 1977;267:531–532.
   PubMed Web of Science ®Google Scholar

• Early demonstration of the key phenotype switch in chondrocytes

• Yoo JU, Mandell I, Angele P, et al. Chondrogenitor cells and gene therapy. Clin Orthop. 2000;379 Suppl:S164–70.
   Google Scholar
• Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004;36(4):568–584.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Cooper GM, Gharaibeh B, et al. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum. 2009;60(5):1390–1405.
   PubMed Web of Science ®Google Scholar
• Evans CH, Scully SP. Orthopaedic gene therapy. Clin Orthop. 2000;379 Suppl:S2.
   Google Scholar
• Evans CH, Robbins PD, Ghivizzani SC, et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther. 1996;7(10):1261–1280.
   PubMed Web of Science ®Google Scholar

•• Initial clinical trial for cartilage gene therapy.

• Wehling P, Reinecke J, Baltzer AW, et al. Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis. Hum Gene Ther. 2009;20(2):97–101.
   PubMed Web of Science ®Google Scholar
• Ha CW, Noh MJ, Choi KB, et al. Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients. Cytotherapy. 2012;14(2):247–256.
   PubMed Web of Science ®Google Scholar

•• Milestone clinical trial for osteoarthritis gene therapy.

• Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494–502.
   PubMed Web of Science ®Google Scholar
• Van Beuningen HM, Van Der Kraan PM, Arntz OJ, et al. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest. 1994;71(2):279–290.
   PubMed Web of Science ®Google Scholar
• Yonekura A, Osaki M, Hirota Y, et al. Transforming growth factor-beta stimulates articular chondrocyte cell growth through p44/42 MAP kinase (ERK) activation. Endocr J. 1999;46(4):545–553.
   PubMed Web of Science ®Google Scholar
• Glansbeek HL, Van Beuningen HM, Vitters EL, et al. Stimulation of articular cartilage repair in established arthritis by local administration of transforming growth factor-beta into murine knee joints. Lab Invest. 1998;78(2):133–142.
   PubMed Web of Science ®Google Scholar
• Noh MJ, Copeland RO, Yi Y, et al. Pre-clinical studies of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 (TG-C). Cytotherapy. 2010;12(3):384–393.
   PubMed Web of Science ®Google Scholar
• Ha CW, Cho JJ, Elmallah RK, et al. A multicenter, single-blind, phase IIa clinical trial to evaluate the efficacy and safety of a cell-mediated gene therapy in degenerative knee arthritis patients. Hum Gene Ther Clin Dev. 2015;26(2):125–130. doi:10.1089/humc.2014.145
   PubMed Web of Science ®Google Scholar

•• Milestone clinical trial for osteoarthritis gene therapy.

• Lee MC, Ha CW, Elmallah RK, et al. A placebo-controlled randomised trial to assess the effect of TGF-ss1-expressing chondrocytes in patients with arthritis of the knee. Bone Joint J. 2015;97-B(7):924–932.
   PubMed Web of Science ®Google Scholar

•• Milestone clinical trial for osteoarthritis gene therapy.

• Van Der Kraan PM, Van Den Berg WB. Osteophytes: relevance and biology. Osteoarthr Cartil. 2007;15(3):237–244.
   PubMed Web of Science ®Google Scholar
• Hunziker EB, Driesang IM, Morris EA. Chondrogenesis in cartilage repair is induced by members of the transforming growth factor-beta superfamily. Clin Orthop. 2001;391 Suppl:S171–S181.
   Google Scholar
• Mierisch CM, Cohen SB, Jordan LC, et al. Transforming growth factor-beta in calcium alginate beads for the treatment of articular cartilage defects in the rabbit. Arthroscopy. 2002;18(8):892–900.
   PubMed Web of Science ®Google Scholar
• Evans CH, Ghivizzani SC, Robbins PD. Arthritis gene therapy and its tortuous path into the clinic. Transl Res. 2013;161(4):205–216. doi:10.1016/j.trsl.2013.01.002
   PubMed Web of Science ®Google Scholar
• Goodrich LR, Grieger JC, Phillips JN, et al. scAAVIL-1ra dosing trial in a large animal model and validation of long-term expression with repeat administration for osteoarthritis therapy. Gene Ther. 2015;22(7):536–545. doi:10.1038/gt.2015.21
   PubMed Web of Science ®Google Scholar

• Milestone study on osteoarthritis gene therapy in vivo.

• Lohmander LS, Hellot S, Dreher D, et al. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 2014;66(7):1820–1831.
   PubMed Web of Science ®Google Scholar

• Important clinical trial for knee osteoarthritis applying a recombinant growth factor.

• Naldini L. Gene therapy returns to centre stage. Nature. 2015;526(7573):351–360.
   PubMed Web of Science ®Google Scholar

• Review on recent clinical trials of gene therapy

• High KA, Aubourg P. rAAV human trial experience. Methods Mol Biol. 2011;807:429–457.
   PubMedGoogle Scholar
• Xiao PJ, Lentz TB, Samulski RJ. Recombinant adeno-associated virus: clinical application and development as a gene-therapy vector. Ther Deliv. 2012;3(7):835–856.
   PubMedGoogle Scholar
• Yla-Herttuala S. Endgame: Glybera finally recommended for approval as the first gene therapy drug in the European Union. Mol Ther. 2012;20(10):1831–1832.
   PubMed Web of Science ®Google Scholar
• Buning H. Gene therapy enters the pharma market: the short story of a long journey. EMBO Mol Med. 2013;5(1):1–3.
   PubMed Web of Science ®Google Scholar

• Review on the first rAAV-based gene therapy drug.